diazoxide has been researched along with Remission, Spontaneous in 3 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gundogdu, S | 3 |
Ciftci, M | 3 |
Atay, E | 3 |
Ayaz, A | 3 |
Ceran, O | 3 |
Atay, Z | 3 |
Karlsson, FA | 1 |
Björk, E | 1 |
Lifschitz, MD | 1 |
Cody, T | 1 |
1 review available for diazoxide and Remission, Spontaneous
Article | Year |
---|---|
Beta-cell rest: a strategy for the prevention of autoimmune diabetes.
Topics: Autoantibodies; Autoantigens; Diabetes Mellitus, Type 1; Diazoxide; Disease Progression; Gene Expres | 1997 |
2 other studies available for diazoxide and Remission, Spontaneous
Article | Year |
---|---|
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Clinical and laboratory evaluation of children with congenital hyperinsulinism: a single center experience.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Potassium Channels, Inwardly Rectifyin | 2023 |
Spontaneous remission of accelerated (malignant) hypertension in renal infarction.
Topics: Adult; Diazoxide; Furosemide; Humans; Hypertension, Malignant; Infarction; Kidney; Male; Methyldopa; | 1977 |